image
Healthcare - Biotechnology - NASDAQ - US
$ 0.8335
-3.45 %
$ 38 M
Market Cap
-0.45
P/E
BALANCE SHEET
81.6 M ASSETS
82.46%
61.8 M LIABILITIES
1218.98%
19.8 M EQUITY
-50.63%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Verrica Pharmaceuticals Inc.
image
Current Assets 77.5 M
Cash & Short-Term Investments 69.5 M
Receivables 4.42 M
Other Current Assets 3.57 M
Non-Current Assets 4.07 M
Long-Term Investments 0
PP&E 3.62 M
Other Non-Current Assets 452 K
Current Liabilities 17 M
Accounts Payable 2.46 M
Short-Term Debt 1.4 M
Other Current Liabilities 13.2 M
Non-Current Liabilities 44.8 M
Long-Term Debt 44.8 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 69.5 34.3 15.8 10.7 9.2 89.8 8.7 0.5
Short Term Investments 0 0 54.6 54.8 52.8 79.5 0 0
Receivables 4.4 0.5 0 0 0 0 0 0
Inventory 1.0 (0.5) 0 0 0 0 0 0
Other Current Assets 2.5 8.7 7.9 4.4 5.9 2.7 0.4 17 K
Total Current Assets 77.5 39.1 74.3 65.5 65.0 89.8 9.1 0.5
PP&E 3.6 5.6 5.8 4.9 2.2 0.3 0 0
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0.4 0 0 0
Other Long Term Assets 0.5 0 0 3.7 0.8 1.8 0 0
Other Assets 0 0 0 0 0 0 0 0
Total Assets 81.6 44.7 80.1 74.2 68.4 91.9 9.1 0.5
LIABILITIES
Accounts Payable 2.5 0.5 0.8 0.3 1.2 0.9 0.2 67 K
Short Term Debt 1.4 0.6 41.9 35.7 0.3 0 0 0
Other Current Liabilities 13.2 2.4 3.3 2.9 1.9 1.6 0.5 0.4
Total Current Liabilities 17.0 3.5 46.1 39.5 3.4 2.5 0.6 0.4
Long Term Debt 44.8 1.2 1.5 1.7 58 K 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 2.8
Total Liabilities 61.8 4.7 47.5 41.2 3.4 2.5 0.6 3.2
EQUITY
Common Stock 4 K 4 K 3 K 3 K 3 K 3 K 2 K 1 K
Retained Earnings (230.4) (163.5) (139.0) (103.9) (61.2) (33.1) (12.4) (2.7)
Other Accumulative Comprehensive Income/Loss 0 0 29 K 1 K 20 K 17 K (15.5) 1 K
Total Equity 19.8 40.0 32.6 33.0 65.0 89.4 8.5 (2.7)
Total Liabilities and Equity 81.6 44.7 80.1 74.2 68.4 91.9 9.1 0.5
SHARES OUTSTANDING
Common Shares Outstanding 45.3 34.2 27.0 25.0 24.9 14.7 19.9 19.9